FindMyKOL
Clinical trialNCT04967521Active, not recruitingPhase 3Interventional

SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma

SponsorSarcoma Alliance for Research through CollaborationEnrollment108Advanced Dedifferentiated Liposarcoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a Phase 3 randomized double-blind study of abemaciclib versus placebo. Patients with progression of disease will cross over to open label abemaciclib.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Colorado Cancer Center, Anschutz Medical Campus

    Aurora, Colorado, United States

  • Mayo Clinic Florida

    Jacksonville, Florida, United States

  • Northwestern University

    Chicago, Illinois, United States

  • Massachusetts General Hospital Cancer Center

    Boston, Massachusetts, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

  • Duke University

    Durham, North Carolina, United States

  • Oregon Health & Science University

    Portland, Oregon, United States

  • University of Washington

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Abemaciclib →Placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
11 Nov 2021
Primary completion
31 Dec 2025
Completion
31 Dec 2026
Last update posted
6 Dec 2024
Registered enrollment
108
Registry id
NCT04967521
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.